Hints and tips:
Related Topics
...Shkreli then plundered funds from Retrophin, one of the biotech companies he founded, to cover up the losses and reimburse investors, federal prosecutors said — although jurors acquitted Shkreli of the charge...
...He counters that he eventually transferred Retrophin stock to the fund which “ended up working out great and the punters made a fortune”....
...– A Shkreli trial update from Reuters: The CEO of Retrophin Inc, the drug company that Martin Shkreli founded and is now accused of conspiring to defraud, compared Shkreli to the Pied Piper on Thursday...
...He is also prohibited from having contact with current or former employees of Retrophin or MSMB funds. He was sacked by Retrophin in 2014* for “serious concerns about his conduct”....
...A spokeswoman for Retrophin said: “The directors of Retrophin replaced Martin Shkreli as chief executive more than a year ago because of serious concerns about his conduct....
Gouging has made reform inevitable; it should be market-based
...While at Retrophin, Mr Shkreli sued Thomas Pierotti, a former employee, alleging he transferred Retrophin shares worth $3m into his own trading account....
...on the Nasdaq biotech index, shares of 137 groups have fallen over the past two days, including drops of more than 15 per cent by Bluebird Bio, Ultragenyx Pharmaceutical, Horizon Pharma, ImmunoGen and Retrophin...
International Edition